Slow Release Oral Morphine Versus Methadone for the Treatment of Opioid Use Disorder

BMJ Open - United Kingdom
doi 10.1136/bmjopen-2018-025799
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

BMJ

Related search

Extended-Release Naltrexone Versus Standard Oral Naltrexone Versus Placebo for Opioid Use Disorder: The NEAT Three-Arm RCT

Health Technology Assessment
MedicineHealth Policy
2019English

Slow Release Morphine Did Not Reduce Neonatal Abstinence Syndrome More Than Methadone

Evidence-Based Mental Health
PsychiatryMental Health
1999English

Opioid Users' Willingness to Receive Prolonged-Release Buprenorphine Depot Injections for Opioid Use Disorder

Journal of Substance Abuse Treatment
MedicineClinical PsychologyPsychiatryPsychiatric Mental HealthMental Health
2019English

Opioid–galanin Receptor Heteromers Differentiate the Dopaminergic Effects of Morphine and Methadone

Journal of Clinical Investigation
Medicine
2019English

Sustained-Release Subdermal Buprenorphine Implants: The Future of Opioid Use Disorder Management?

Journal of Pharmacy Practice and Research
PharmacologyPharmacy
2019English

Morphine vs Methadone in the Treatment of Neonatal Abstinence Syndrome

Acta Paediatrica, International Journal of Paediatrics
MedicineChild HealthPediatricsPerinatology
2019English

Buprenorphine Maintenance Versus Placebo or Methadone Maintenance for Opioid Dependence

2008English

A Change Management Case Study for Safe Opioid Prescribing and Opioid Use Disorder Treatment

Journal of the American Board of Family Medicine
EnvironmentalPublic HealthFamily PracticeOccupational Health
2020English

Effective Treatment of Opioid Use Disorder Among African Americans

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy